Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)

Completed · Phase 3

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

This study was designed to determine if the investigational drug is effective and safe in individuals with COPD (chronic pulmonary disease)

Key facts

Study ID

NCT00103922

Run by

GlaxoSmithKline

People needed

600

Starts

2004-11-01

Expected to finish

2007-01-01

Last updated by the study team

2016-10-28

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of COPD and a history of cigarette smoking.

You may not qualify if…

• Significant heart or lung disease not associated with COPD.
• Significant stomach or intestinal disease.

Where it is running

• GSK Investigational Site — Jasper, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Tempe, Arizona, United States
• GSK Investigational Site — Berkeley, California, United States
• GSK Investigational Site — Carmichael, California, United States
• GSK Investigational Site — Fullerton, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Murrieta, California, United States
• GSK Investigational Site — Rancho Mirage, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Jose, California, United States
• GSK Investigational Site — Sepulveda, California, United States
• GSK Investigational Site — Stockton, California, United States
• GSK Investigational Site — Torrance, California, United States
• GSK Investigational Site — Vista, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Boulder, Colorado, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.